Monte Rosa Therapeutics
Biotechnology
Monte Rosa Therapeutics valuation and funding history | Last updated: March 12, 2021 | 1 funding rounds
Current Valuation
N/A
As of March 12, 2021
Total Funding Raised
N/A
Across 1 round
Last Round
Later Stage VC (Series C)
$95.0M
Last Funding
Mar 2021
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| March 12, 2021 | Later Stage VC (Series C) | $95.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Monte Rosa Therapeutics is currently valued at N/A as of March 12, 2021.
Explore More Data
Detailed analysis for Monte Rosa Therapeutics
What is Monte Rosa Therapeutics Worth in 2026?
Monte Rosa Therapeutics is a leading private company in the Biotechnology sector. Track Monte Rosa Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Monte Rosa Therapeutics Valuation is Determined
Private company valuations like Monte Rosa Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.